Many popular sequential phase II clinical trial designs optimize some criterion subject to constraints on the error probabilities at null and alternative values of the response rate. Such designs may forfeit optimality if one fails to conduct analyses strictly according to plan. Moreover, a decision
โฆ LIBER โฆ
An introduction to the Bayesian analysis of clinical trials
โ Scribed by Roger J Lewis; Robert L Wears
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 930 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1097-6760
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Bayesian interim analysis of phase II ca
โ
Daniel F. Heitjan
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 111 KB
๐ 2 views
Introduction to the Workshop on Clinical
โ
Dr. Walter Lawrence Jr.
๐
Article
๐
1990
๐
John Wiley and Sons
๐
English
โ 141 KB
๐ 2 views
Introduction to the American cancer soci
โ
Walter Lawrence Jr.
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 64 KB
๐ 3 views
Meta-analysis of clinical trials: Summar
โ
J. P. Boissel; H. S. Sacks; A. Leizorovicz; J. Blanchard; E. Panak; J. C. Peyrie
๐
Article
๐
1988
๐
Springer
๐
English
โ 403 KB
A Bayesian approach to economic analyses
โ
Maiwenn J. Al; Ben A. Van Hout
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 113 KB
๐ 1 views
New results about the costs and effects of a new therapy may be weighted with prior information. As such, classical confidence intervals surrounding the costs and effects of a therapy may not reflect the real uncertainties. Bayesian techniques may improve this by formalizing the way that prior infor
Some problems related to the design and
โ
Ian F. Tannock
๐
Article
๐
1992
๐
Elsevier Science
๐
English
โ 904 KB